Related Experiment Video
Updated: Aug 8, 2026

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
Published on: July 22, 2011
A semiquantitative assay for CD8+ T-cell-mediated suppression of human immunodeficiency virus type 1 infection
1Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health and School of Medicine, Pennsylvania 15261, USA.
Insights
A new assay quantifies CD8+ T cell anti-human immunodeficiency virus type 1 (HIV-1) activity. This reproducible method aids research into HIV-1 natural history, therapy, and vaccine efficacy.
Area of Science:
- Immunology
- Virology
- Cellular Biology
Background:
- CD8+ T cells play a crucial role in controlling viral infections, including human immunodeficiency virus type 1 (HIV-1).
- Quantifying the suppressive activity of CD8+ T cells is essential for understanding HIV-1 pathogenesis and evaluating therapeutic interventions.
- Existing methods may have limitations in sensitivity, dynamic range, or applicability to various sample types.
Purpose of the Study:
- To develop and validate a reproducible, semiquantitative assay for measuring the anti-HIV-1 suppressive activity of CD8+ T cells.
- To characterize the nature of the CD8+ T cell-mediated suppression.
- To establish an assay applicable to both fresh and cryopreserved cells for broad utility.
Main Methods:
- Development of a semiquantitative assay to measure CD8+ T cell suppressive activity against HIV-1.
- Application of the assay to fresh and cryopreserved peripheral blood mononuclear cells (PBMCs) and purified CD8+ T cells.
- Characterization of suppressive activity regarding cytolytic mechanisms and MHC class I restriction.
Main Results:
- The assay demonstrated reproducibility and a wide dynamic range.
- Suppressive activity could be measured using small numbers of fresh and cryopreserved cells.
- The suppressive activity was independent of cytolytic activity and MHC class I restriction.
- Consistent suppression was observed with both autologous and allogeneic CD4+ T cells.
Conclusions:
- A robust assay for quantifying CD8+ T cell anti-HIV-1 activity has been established.
- This assay is suitable for diverse sample types and conditions, facilitating widespread use.
- The assay provides a valuable tool for monitoring antiviral responses in HIV-1 research, clinical trials, and vaccine studies.
Abstract:
A reproducible, semiquantitative assay was developed to measure the level of the anti-human immunodeficiency virus type 1 (anti-HIV-1) suppressive activity of CD8+ T cells. The assay had a wide dynamic range and could be applied to a relatively small number of fresh and cryopreserved peripheral blood mononuclear cells and purified CD8+ T cells. The suppressive activity was not due to cytolytic activity and was not major histocompatibility complex class I restricted. Suppression of HIV-1 infection by CD8+ T cells was consistently demonstrable with both endogenously infected autologous CD4+ T cells and exogenously infected allogeneic CD4+ T cells. This assay can be used to monitor the level of antiviral activity of CD8+ T cells in a retrospective and prospective manner in studies of the natural history of HIV-1 infection and of subjects receiving anti-HIV-1 therapy and vaccines.
More Related Videos
09:26In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 16, 2013
07:17Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
Published on: June 22, 2016